Scientific Programme

Main Topics

  • Digital MS: Leveraging “big data” 
  • Treatment of relapsing and progressive MS
  • Risk management with MS therapies
  • How real world data inform treatment decisions
  • Biosimilars and follow-ups
  • Immunopathology of MS
  • New targets for fighting neurodegeneration
  • Molecular imaging
  • Emerging high throughput technologies

The preliminary programme will be available in spring 2018.